- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Histone Deacetylase Inhibitors
Total 64228 results
-
Massachusetts General HospitalMerck Sharp & Dohme LLC; Dana-Farber Cancer Institute; Brigham and Women's HospitalTerminatedPancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
University of VirginiaCompletedNon Small Cell Lung CancerUnited States
-
Bayside HealthMerck Sharp & Dohme LLCUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
M.D. Anderson Cancer CenterWithdrawn
-
National Cancer Institute (NCI)TerminatedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage... and other conditionsCanada, United States
-
Merck Sharp & Dohme LLCTerminatedBreast Cancer | Colorectal Cancer | Non-small-cell Lung Carcinoma
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; CelgeneCompleted
-
Gynecologic Oncology AssociatesMerck Sharp & Dohme LLCTerminatedOvarian NeoplasmsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
CelgeneThe Leukemia and Lymphoma SocietyCompletedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Patrick Y. Wen, MDMassachusetts General Hospital; Northwestern University; Novartis; Beth Israel... and other collaboratorsCompleted
-
Tulane University Health Sciences CenterNovartis; Board of Regents, State of LouisianaWithdrawnBreast CancerUnited States
-
Duke UniversityMerck Sharp & Dohme LLC; Genentech, Inc.CompletedMalignant Glioma | Recurrent Glioblastoma Multiforme | Adult Brain TumorUnited States
-
Medical University of South CarolinaNovartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Renal Cancer | Non Small Cell Lung Cancer (NSCLC)United States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
H. Lee Moffitt Cancer Center and Research InstituteSchering-PloughTerminatedPhase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain MetastasesBrain MetastasesUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...NovartisTerminatedBrain Metastasis | Recurrent Glioma | High-grade MeningiomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung CarcinomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Merck Sharp & Dohme LLCCompletedBrain MetastasesUnited States
-
Anne Beaven, MDNovartisTerminatedDiffuse Large B-cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Novartis PharmaceuticalsWithdrawn
-
Angimmune LLCUniversity of Colorado, Denver; Washington University School of Medicine; Yale... and other collaboratorsUnknown
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
Chong Kun Dang PharmaceuticalCompletedLymphoma | Multiple MyelomaKorea, Republic of
-
Milton S. Hershey Medical CenterTerminatedNon-small Cell Lung CancerUnited States
-
Translational Research in OncologyCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Tiziana MarangonWithdrawn
-
Novartis PharmaceuticalsTerminatedBreast CancerFrance, Canada, United Kingdom, Germany, Italy, United States
-
M.D. Anderson Cancer CenterWithdrawn
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedEpithelial Ovarian Cancer | Non-small Cell Lung CancerRussian Federation
-
Samsung Medical CenterSeok Jin KimTerminatedMantle Cell LymphomaKorea, Republic of
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
Instituto do Cancer do Estado de São PauloUniversity of Sao PauloCompletedHead and Neck Cancer | Oropharyngeal Cancer | Oral Cavity CancerBrazil
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Merck Sharp & Dohme LLCTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaAustralia
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, IncWithdrawn